{"id":416215,"date":"2021-01-18T19:34:35","date_gmt":"2021-01-19T00:34:35","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=416215"},"modified":"2021-01-18T19:34:35","modified_gmt":"2021-01-19T00:34:35","slug":"quest-diagnostics-granted-cdc-contract-to-sequence-covid-19-gene-variants-to-aid-public-health-response-to-covid-19","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/quest-diagnostics-granted-cdc-contract-to-sequence-covid-19-gene-variants-to-aid-public-health-response-to-covid-19\/","title":{"rendered":"Quest Diagnostics Granted CDC Contract to Sequence COVID-19 Gene Variants to Aid Public Health Response to COVID-19"},"content":{"rendered":"
\n

Quest’s genomic sequencing and infectious disease expertise will identify novel SARS-CoV-2 mutations, providing insights on prevalence and transmission in the United States<\/h2>\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n SECAUCUS, N.J.<\/span>, Jan. 18, 2021<\/span> \/PRNewswire\/ —\u00a0Quest Diagnostics<\/b><\/a>\u00a0<\/b>(NYSE: DGX), the world’s leading provider of diagnostic information services, today announced that it has entered into an agreement with the\u00a0Centers for Disease Control and Prevention<\/a>\u00a0(CDC) to provide genomic sequencing to identify new mutations in, and patterns of transmission of SARS-CoV-2, the virus that causes COVID-19. Financial terms of the agreement are not disclosed. <\/p>\n

\n

\n
\n \"Quest
\n <\/a>\n <\/p>\n<\/p><\/div>\n

The goal of the collaboration is to aid the\u00a0CDC\u00a0in conducting a large-scale longitudinal genomic survey of the SARS-CoV-2 virus using a random set of samples collected from Quest’s labs across\u00a0the United States<\/span>. The company will perform the sequencing from its advanced diagnostics laboratory in San Juan Capistrano, Calif.<\/span><\/p>\n

Viruses can mutate over time. In recent weeks, highly transmissible variants of the SARS-CoV-2 virus first discovered in the United Kingdom<\/span> and South Africa<\/span> have been identified in the United States<\/span>. \u00a0<\/p>\n

Quest Diagnostics will sequence the viral genomes of random de-identified samples that test positive in the course of providing molecular diagnostic testing for SARS-CoV-2 for providers and patients, and provide the\u00a0CDC\u00a0with completed whole viral sequences. These data will be combined with the results of other data provided to the CDC by national, state, academic, and commercial labs to help meet the CDC survey’s aims. <\/p>\n

“Public and private collaboration is essential to mobilizing an effective response to COVID-19,” said Jay G. Wohlgemuth<\/span>, M.D., Senior Vice President and Chief Medical Officer. “Quest has the expertise in genomics and infectious diseases, as well as extensive COVID-19 testing data and access to patient samples.\u00a0 Our program will complement and extend the efforts of the CDC to discover and track new virus mutations and thereby improve public health response to the pandemic.”<\/p>\n

The CDC’s survey aims to provide important baseline information for national and state-level surveillance, help define changes in transmission, identify new variants of the virus, and improve the public health response to the virus. <\/p>\n

Quest Diagnostics and the CDC have a long history of collaboration to improve public health initiatives. Most recently, Quest joined the CDC’s seroprevalence survey<\/a>, which analyzes results of de-identified COVID-19 antibody tests to identify rates of COVID-19 prevalence in the United States<\/span>. In addition, Quest is a member of the SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology and Surveillance (SPHERES)<\/a>\u00a0consortium, which launched in May 2020<\/span>. Quest and the CDC are also long-time collaborators to identify trends in screening, diagnosis and treatment in viral hepatitis, HIV and sexually transmitted infections in\u00a0the United States<\/span>, based on insights revealed by analysis of Quest’s national testing database.\u00a0<\/p>\n

\n About COVID-19 Testing at Quest Diagnostics<\/b>\n <\/p>\n

Quest Diagnostics is\u202fat the forefront of the response to the COVID-19 pandemic, working to broaden access to laboratory insights to help us all lead healthier lives. We provide both molecular\u202fdiagnostic and antibody\u202fserology\u202ftests to\u202faid in\u202fthe diagnosis of COVID-19 and immune response. Through\u202four team of\u202fdedicated\u202fphlebotomists, air fleet team, couriers and\u202flaboratory professionals, Quest Diagnostics\u202fworks hard every day to help patients and communities across the United States<\/span> access quality\u202fCOVID-19 testing.\u202f<\/p>\n

For more information about the latest developments with our COVID-19 testing, visit: newsroom.questdiagnostics.com\/COVIDTestingUpdates<\/p>\n

\n About Quest Diagnostics<\/b>\n <\/p>\n

Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world’s largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in\u202fthe\u202fUnited States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.\u202fLearn more about Quest Diagnostics at www.QuestDiagnostics.com<\/a> or follow us on social media: Linkedin<\/a>, Twitter<\/a>, Facebook<\/a>\u00a0and Instagram<\/a>. <\/p>\n

<\/div>\n

\n \"Cision\" View original content to download multimedia:http:\/\/www.prnewswire.com\/news-releases\/quest-diagnostics-granted-cdc-contract-to-sequence-covid-19-gene-variants-to-aid-public-health-response-to-covid-19-301209723.html<\/a><\/p>\n

SOURCE Quest Diagnostics<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Quest’s genomic sequencing and infectious disease expertise will identify novel SARS-CoV-2 mutations, providing insights on prevalence and transmission in the United States PR Newswire SECAUCUS, N.J., Jan. 18, 2021 \/PRNewswire\/ —\u00a0Quest Diagnostics\u00a0(NYSE: DGX), the world’s leading provider of diagnostic information services, today announced that it has entered into an agreement with the\u00a0Centers for Disease Control and Prevention\u00a0(CDC) to provide genomic sequencing to identify new mutations in, and patterns of transmission of SARS-CoV-2, the virus that causes COVID-19. Financial terms of the agreement are not disclosed. The goal of the collaboration is to aid the\u00a0CDC\u00a0in conducting a large-scale longitudinal genomic survey of the SARS-CoV-2 virus using a random set of samples collected from Quest’s labs across\u00a0the United States. The company will … <\/p>\n

Continue reading “Quest Diagnostics Granted CDC Contract to Sequence COVID-19 Gene Variants to Aid Public Health Response to COVID-19”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-416215","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nQuest Diagnostics Granted CDC Contract to Sequence COVID-19 Gene Variants to Aid Public Health Response to COVID-19 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/quest-diagnostics-granted-cdc-contract-to-sequence-covid-19-gene-variants-to-aid-public-health-response-to-covid-19\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Quest Diagnostics Granted CDC Contract to Sequence COVID-19 Gene Variants to Aid Public Health Response to COVID-19 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Quest’s genomic sequencing and infectious disease expertise will identify novel SARS-CoV-2 mutations, providing insights on prevalence and transmission in the United States PR Newswire SECAUCUS, N.J., Jan. 18, 2021 \/PRNewswire\/ —\u00a0Quest Diagnostics\u00a0(NYSE: DGX), the world’s leading provider of diagnostic information services, today announced that it has entered into an agreement with the\u00a0Centers for Disease Control and Prevention\u00a0(CDC) to provide genomic sequencing to identify new mutations in, and patterns of transmission of SARS-CoV-2, the virus that causes COVID-19. Financial terms of the agreement are not disclosed. The goal of the collaboration is to aid the\u00a0CDC\u00a0in conducting a large-scale longitudinal genomic survey of the SARS-CoV-2 virus using a random set of samples collected from Quest’s labs across\u00a0the United States. The company will … Continue reading "Quest Diagnostics Granted CDC Contract to Sequence COVID-19 Gene Variants to Aid Public Health Response to COVID-19"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/quest-diagnostics-granted-cdc-contract-to-sequence-covid-19-gene-variants-to-aid-public-health-response-to-covid-19\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-19T00:34:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/200883\/quest_diagnostics_incorporated_logo_logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quest-diagnostics-granted-cdc-contract-to-sequence-covid-19-gene-variants-to-aid-public-health-response-to-covid-19\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quest-diagnostics-granted-cdc-contract-to-sequence-covid-19-gene-variants-to-aid-public-health-response-to-covid-19\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Quest Diagnostics Granted CDC Contract to Sequence COVID-19 Gene Variants to Aid Public Health Response to COVID-19\",\"datePublished\":\"2021-01-19T00:34:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quest-diagnostics-granted-cdc-contract-to-sequence-covid-19-gene-variants-to-aid-public-health-response-to-covid-19\\\/\"},\"wordCount\":688,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quest-diagnostics-granted-cdc-contract-to-sequence-covid-19-gene-variants-to-aid-public-health-response-to-covid-19\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/200883\\\/quest_diagnostics_incorporated_logo_logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quest-diagnostics-granted-cdc-contract-to-sequence-covid-19-gene-variants-to-aid-public-health-response-to-covid-19\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quest-diagnostics-granted-cdc-contract-to-sequence-covid-19-gene-variants-to-aid-public-health-response-to-covid-19\\\/\",\"name\":\"Quest Diagnostics Granted CDC Contract to Sequence COVID-19 Gene Variants to Aid Public Health Response to COVID-19 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quest-diagnostics-granted-cdc-contract-to-sequence-covid-19-gene-variants-to-aid-public-health-response-to-covid-19\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quest-diagnostics-granted-cdc-contract-to-sequence-covid-19-gene-variants-to-aid-public-health-response-to-covid-19\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/200883\\\/quest_diagnostics_incorporated_logo_logo.jpg\",\"datePublished\":\"2021-01-19T00:34:35+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quest-diagnostics-granted-cdc-contract-to-sequence-covid-19-gene-variants-to-aid-public-health-response-to-covid-19\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quest-diagnostics-granted-cdc-contract-to-sequence-covid-19-gene-variants-to-aid-public-health-response-to-covid-19\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quest-diagnostics-granted-cdc-contract-to-sequence-covid-19-gene-variants-to-aid-public-health-response-to-covid-19\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/200883\\\/quest_diagnostics_incorporated_logo_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/200883\\\/quest_diagnostics_incorporated_logo_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quest-diagnostics-granted-cdc-contract-to-sequence-covid-19-gene-variants-to-aid-public-health-response-to-covid-19\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Quest Diagnostics Granted CDC Contract to Sequence COVID-19 Gene Variants to Aid Public Health Response to COVID-19\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Quest Diagnostics Granted CDC Contract to Sequence COVID-19 Gene Variants to Aid Public Health Response to COVID-19 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/quest-diagnostics-granted-cdc-contract-to-sequence-covid-19-gene-variants-to-aid-public-health-response-to-covid-19\/","og_locale":"en_US","og_type":"article","og_title":"Quest Diagnostics Granted CDC Contract to Sequence COVID-19 Gene Variants to Aid Public Health Response to COVID-19 - Market Newsdesk","og_description":"Quest’s genomic sequencing and infectious disease expertise will identify novel SARS-CoV-2 mutations, providing insights on prevalence and transmission in the United States PR Newswire SECAUCUS, N.J., Jan. 18, 2021 \/PRNewswire\/ —\u00a0Quest Diagnostics\u00a0(NYSE: DGX), the world’s leading provider of diagnostic information services, today announced that it has entered into an agreement with the\u00a0Centers for Disease Control and Prevention\u00a0(CDC) to provide genomic sequencing to identify new mutations in, and patterns of transmission of SARS-CoV-2, the virus that causes COVID-19. Financial terms of the agreement are not disclosed. The goal of the collaboration is to aid the\u00a0CDC\u00a0in conducting a large-scale longitudinal genomic survey of the SARS-CoV-2 virus using a random set of samples collected from Quest’s labs across\u00a0the United States. The company will … Continue reading \"Quest Diagnostics Granted CDC Contract to Sequence COVID-19 Gene Variants to Aid Public Health Response to COVID-19\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/quest-diagnostics-granted-cdc-contract-to-sequence-covid-19-gene-variants-to-aid-public-health-response-to-covid-19\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-19T00:34:35+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/200883\/quest_diagnostics_incorporated_logo_logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quest-diagnostics-granted-cdc-contract-to-sequence-covid-19-gene-variants-to-aid-public-health-response-to-covid-19\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quest-diagnostics-granted-cdc-contract-to-sequence-covid-19-gene-variants-to-aid-public-health-response-to-covid-19\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Quest Diagnostics Granted CDC Contract to Sequence COVID-19 Gene Variants to Aid Public Health Response to COVID-19","datePublished":"2021-01-19T00:34:35+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quest-diagnostics-granted-cdc-contract-to-sequence-covid-19-gene-variants-to-aid-public-health-response-to-covid-19\/"},"wordCount":688,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quest-diagnostics-granted-cdc-contract-to-sequence-covid-19-gene-variants-to-aid-public-health-response-to-covid-19\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/200883\/quest_diagnostics_incorporated_logo_logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quest-diagnostics-granted-cdc-contract-to-sequence-covid-19-gene-variants-to-aid-public-health-response-to-covid-19\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/quest-diagnostics-granted-cdc-contract-to-sequence-covid-19-gene-variants-to-aid-public-health-response-to-covid-19\/","name":"Quest Diagnostics Granted CDC Contract to Sequence COVID-19 Gene Variants to Aid Public Health Response to COVID-19 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quest-diagnostics-granted-cdc-contract-to-sequence-covid-19-gene-variants-to-aid-public-health-response-to-covid-19\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quest-diagnostics-granted-cdc-contract-to-sequence-covid-19-gene-variants-to-aid-public-health-response-to-covid-19\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/200883\/quest_diagnostics_incorporated_logo_logo.jpg","datePublished":"2021-01-19T00:34:35+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quest-diagnostics-granted-cdc-contract-to-sequence-covid-19-gene-variants-to-aid-public-health-response-to-covid-19\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/quest-diagnostics-granted-cdc-contract-to-sequence-covid-19-gene-variants-to-aid-public-health-response-to-covid-19\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quest-diagnostics-granted-cdc-contract-to-sequence-covid-19-gene-variants-to-aid-public-health-response-to-covid-19\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/200883\/quest_diagnostics_incorporated_logo_logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/200883\/quest_diagnostics_incorporated_logo_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quest-diagnostics-granted-cdc-contract-to-sequence-covid-19-gene-variants-to-aid-public-health-response-to-covid-19\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Quest Diagnostics Granted CDC Contract to Sequence COVID-19 Gene Variants to Aid Public Health Response to COVID-19"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/416215","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=416215"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/416215\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=416215"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=416215"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=416215"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}